Direct oral anticoagulants in patients with hypertrophic cardiomyopathy and atrial fibrillation

Chronic anticoagulation with vitamin K antagonists (VKAs) is recommended in patients with hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF). Direct oral anticoagulants (NOACs) are an alternative to VKAs but there are limited data to support their use in HCM. We sought to describe the pa...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cardiology 2017-12, Vol.248, p.232-238
Hauptverfasser:	Dominguez, Fernando, Climent, Vicente, Zorio, Esther, Ripoll-Vera, Tomás, Salazar-Mendiguchía, Joel, García-Pinilla, Jose Manuel, Urbano-Moral, Jose Angel, Fernández-Fernández, Xusto, Lopez-Cuenca, David, Ajo-Ferrer, Raquel, Sanz-Sanchez, Jorge, Gomez-Perez, Yolanda, López-Garrido, Miguel A., Barriales-Villa, Roberto, Gimeno, Juan Ramón, Garcia-Pavia, Pablo
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Aged Anticoagulants - administration & dosage Anticoagulation Atrial fibrillation Atrial Fibrillation - diagnosis Atrial Fibrillation - drug therapy Atrial Fibrillation - epidemiology Cardiomyopathy, Hypertrophic - diagnosis Cardiomyopathy, Hypertrophic - drug therapy Cardiomyopathy, Hypertrophic - epidemiology Cohort Studies Female Follow-Up Studies Humans Hypertrophic cardiomyopathy Longitudinal Studies Male Middle Aged Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!